表紙:マラリア診断の市場規模・市場シェア・動向分析 (2022-2030年):技術 (顕微鏡検査・迅速診断検査・分子診断検査)・地域別
市場調査レポート
商品コード
1092677

マラリア診断の市場規模・市場シェア・動向分析 (2022-2030年):技術 (顕微鏡検査・迅速診断検査・分子診断検査)・地域別

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic tests, Molecular Diagnostic Tests), By Region, And Segment Forecasts, 2022 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 84 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.46円
マラリア診断の市場規模・市場シェア・動向分析 (2022-2030年):技術 (顕微鏡検査・迅速診断検査・分子診断検査)・地域別
出版日: 2022年05月19日
発行: Grand View Research
ページ情報: 英文 84 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のマラリア診断の市場規模は予測期間中5.4%のCAGRで推移し、2030年には12億米ドルの規模に成長すると予測されています。

熱帯病の蔓延、新しい診断技術の開発、地域の政府や民間投資家による投資の増加が同市場の成長を促進すると期待されています。また、新型コロナウイルス感染症 (COVID-19) 流行時には、アフリカ地域で豊富に入手可能な抗マラリア薬の治療オプションが、感染拡大の管理と制御に使用されました。

当レポートでは、世界のマラリア診断の市場を調査し、市場概要、市場成長への各種影響因子の分析、法規制環境、技術動向、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、市場シェア、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法・調査範囲

第2章 エグゼクティブサマリー

第3章 市場可変因子・動向・展望

  • 市場系統の見通し
  • 普及・成長の見通しマッピング
  • 産業のバリューチェーン分析
  • 技術概要
  • 規制の枠組み
  • 市場力学
  • 市場分析ツール

第4章 マラリア診断市場:競合分析

  • 主要企業・近年の展開・影響分析
  • ベンダー情勢
  • 公開会社
  • 非公開会社

第5章 マラリア診断市場:技術別の推計・動向分析

  • 定義・範囲
  • 市場シェア分析
  • セグメントダッシュボード
  • 世界のマラリア診断市場:技術別
  • 市場規模の予測・動向分析
    • 顕微鏡検査
    • 迅速診断検査
    • 分子診断検査

第6章 マラリア診断市場:地域・技術別の推計・動向分析

  • 地域市場のスナップショット
  • 地域の市場シェア・主要企業
  • 市場シェア分析:国/州別
  • SWOT分析
  • 市場規模の予測・動向分析
  • アフリカ
  • 東南アジア
  • 地中海東岸
  • 西太平洋
  • 南北アメリカ
  • 欧州

第7章 企業プロファイル

  • Access Bio, Inc.
  • Abbott
  • Premier Medical Corporation Ltd
  • Sysmex Partec GmbH
  • bioMerieux
  • Beckman Coulter, Inc.
  • Siemens Healthineers
  • Leica Microsystems GmbH
  • Nikon Corporation
  • Olympus Corporation
  • Bio-Rad Laboratories, Inc.
図表

List of Tables

  • TABLE 1 Factors used in segment share estimation
  • TABLE 2 List of secondary data sources
  • TABLE 3 Africa malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 4 Africa malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 5 Africa malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 6 Nigeria malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 7 Nigeria malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 8 Democratic Republic of Congo malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 9 Congo malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 10 Uganda malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 11 Uganda malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 12 South East Asia malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 13 South East Asia malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 14 South East Asia malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 15 India malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 16 India malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 17 Myanmar malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 18 Myanmar malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 19 Indonesia malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 20 Indonesia malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 21 Eastern Mediterranean malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 22 Eastern Mediterranean malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 23 Eastern Mediterranean malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 24 Saudi Arabia malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 25 Saudi Arabia malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 26 Pakistan malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 27 Pakistan malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 28 Western Pacific malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 29 Western Pacific malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 30 Western Pacific malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 31 China malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 32 China malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 33 Papua New Guinea malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 34 Papua New Guinea malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 35 Cambodia malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 36 Cambodia malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 37 Americas malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 38 Americas malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 39 Americas malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 40 Venezuela malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 41 Venezuela malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 42 Brazil malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 43 Brazil malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 44 Colombia malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 45 Colombia malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 46 Europe malaria diagnostics market, by country, 2017 - 2030 (USD Million)
  • TABLE 47 Europe malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 48 Europe malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 49 Turkey malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 50 Turkey malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 51 France malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 52 France malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 53 U.K. malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 54 U.K. malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)
  • TABLE 55 Germany malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • TABLE 56 Germany malaria diagnostics market, by molecular diagnostic tests, 2017 - 2030 (USD Million)

List of Figures

  • FIG. 1 Malaria diagnostics market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Information procurement
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value chain based sizing & forecasting
  • FIG. 7 QFD modelling for market share assessment
  • FIG. 8 Malaria diagnostics market snapshot (2021)
  • FIG. 9 Malaria diagnostics market: Segment snapshot (2021)
  • FIG. 10 Competitive Insights (2021)
  • FIG. 11 Parent market outlook
  • FIG. 12 Related/ancillary market outlook
  • FIG. 13 Penetration and growth prospect mapping
  • FIG. 14 Industry value chain analysis
  • FIG. 15 Consumer Behavior Analysis
  • FIG. 16 Technology timeline
  • FIG. 17 Malaria diagnostics market driver impact
  • FIG. 18 Malaria diagnostics market restraint impact
  • FIG. 19 Malaria diagnostics industry challenges
  • FIG. 20 Porter's Five Forces Analysis
  • FIG. 21 SWOT Analysis, By Factor (Political & legal Economic and technological)
  • FIG. 22 Strategic Alliance Analysis
  • FIG. 23 Recent Developments & Impact Analysis, By Key Market Participants
  • FIG. 24 Key company market share analysis, 2021
  • FIG. 25 Company market position analysis
  • FIG. 26 Company Market Share/Ranking, by region
  • FIG. 27 Competitive dashboard analysis
  • FIG. 28 Company market position analysis
  • FIG. 29 Supplier Ranking
  • FIG. 30 Definition and Scope, by technology
  • FIG. 31 Technology market share analysis, 2021 & 2030
  • FIG. 32 Segment Dashboard
  • FIG. 33 Global malaria diagnostics market, by technology, 2017 - 2030 (USD Million)
  • FIG. 34 Microscopy Market Size & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • FIG. 35 Rapid Diagnostic Tests (RDTs) Market Size & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • FIG. 36 Molecular Diagnostic Tests (MDTs) Market Size & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • FIG. 37 Malaria diagnostics market: Snapshot, 2021
  • FIG. 38 Africa malaria diagnostics market share and leading players, 2021
  • FIG. 39 South East Asia malaria diagnostics market share and leading players, 2021
  • FIG. 40 Eastern Mediterranean malaria diagnostics market share and leading players, 2021
  • FIG. 41 Western Pacific malaria diagnostics market share and leading players, 2021
  • FIG. 42 Americas malaria diagnostics market share and leading players, 2021
  • FIG. 43 Europe malaria diagnostics market share and leading players, 2021
  • FIG. 44 Africa market share analysis by country, 2021
  • FIG. 45 South East Asia market share analysis by country, 2021
  • FIG. 46 Eastern Mediterranean market share analysis by country, 2021
  • FIG. 47 Western Pacific market share analysis by country, 2021
  • FIG. 48 Americas market share analysis by country, 2021
  • FIG. 49 Europe market share analysis by country, 2021
  • FIG. 50 Africa SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 51 South East Asia SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 52 Eastern Mediterranean SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 53 Western Pacific SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 54 Americas SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 55 Europe SWOT analysis, by factor (political & legal, economic and technological)
  • FIG. 56 Africa market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 57 Nigeria market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 58 Democratic Republic of Congo market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 59 Uganda market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 60 South East Asia market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 61 India market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 62 Myanmar market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 63 Indonesia market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 64 Eastern Mediterranean market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 65 Saudi Arabia market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 66 Pakistan market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 67 Western Pacific market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 68 China market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 69 Papua New Guinea market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 70 Cambodia market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 71 Americas market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 72 Venezuela market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 73 Brazil market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 74 Colombia market size, & forecasts and trend analysis, 2017 to 2030(USD Million)
  • FIG. 75 Europe market size, & forecasts and trend analysis, 2017 to 2030(USD Million)
  • FIG. 76 Turkey market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 77 France market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 78 U.K. market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
  • FIG. 79 Germany market size, & forecasts and trend analysis, 2017 to 2030 (USD Million)
目次
Product Code: 978-1-68038-711-7

Malaria Diagnostics Market Growth & Trends:

The global malaria diagnostics market size is projected to reach USD 1.2 billion by 2030, expanding at a CAGR of 5.4%, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights:

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count
  • Africa led the market in 2021 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region
  • Southeast Asia also held a considerable revenue share in 2018 owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Market Definition
  • 1.3 Information Procurement
    • 1.3.1 Purchased database
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources & third party perspectives
    • 1.3.4 Primary research
  • 1.4 Information Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market formulation & data visualization
  • 1.6 Data Validation & Publishing

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Industry Value Chain Analysis
    • 3.3.1 Raw Material Trends
      • 3.3.1.1 Major Raw Materials Market Analysis
      • 3.3.1.2 Procurement Best Practices
    • 3.3.2 Manufacturing Trends
      • 3.3.2.1 Technology Trends
      • 3.3.2.2 Outsourcing & Contract Manufacturing Trends
      • 3.3.2.3 Cost Structure Analysis
    • 3.3.3 User perspective analysis
      • 3.3.3.1 Consumer Behavior Analysis
      • 3.3.3.2 Market Influencer Analysis
    • 3.3.4 Procedure cost analysis/breakdown
    • 3.3.5 List of Key End-users, by region / by product / by country
  • 3.4 Technology Overview
    • 3.4.1 Technology Timeline
  • 3.5 Regulatory Framework
    • 3.5.1 Reimbursement framework
    • 3.5.2 Standards & Compliances
  • 3.6 Market Dynamics
    • 3.6.1 Market Driver Analysis
      • 3.6.1.1 Increasing demand for diagnostic tools in malaria-endemic countries
      • 3.6.1.2 Development of technologically advanced and efficient diagnostics
      • 3.6.1.3 Market players and private investors to curb the prevalence of malaria
    • 3.6.2 Market Restraint Analysis
      • 3.6.2.1 Increasing number of countries in the malaria elimination phase
      • 3.6.2.2 Demand for low-cost malaria diagnostic tests
    • 3.6.3 Industry Challenges
  • 3.7 Malaria Diagnostics Market Analysis Tools
    • 3.7.1 Industry Analysis - Porter's
      • 3.7.1.1 Supplier Power
      • 3.7.1.2 Buyer Power
      • 3.7.1.3 Substitution Threat
      • 3.7.1.4 Threat from new entrant
      • 3.7.1.5 Competitive rivalry
    • 3.7.2 PESTEL Analysis
      • 3.7.2.1 Political Landscape
      • 3.7.2.2 Environmental Landscape
      • 3.7.2.3 Social Landscape
      • 3.7.2.4 Technology Landscape
      • 3.7.2.5 Legal Landscape
    • 3.7.3 Major Deals & Strategic Alliances Analysis
    • 3.7.4 Market Entry Strategies
    • 3.7.5 Case Studies

Chapter 4 Malaria Diagnostics Market: Competitive Analysis

  • 4.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 4.2 Vendor Landscape
    • 4.2.1 List of key distributors and channel partners
    • 4.2.2 Key customers
    • 4.2.3 Key company market share analysis, 2021
  • 4.3 Public Companies
    • 4.3.1 Company market position analysis
    • 4.3.2 Company market Share/Ranking, by region
    • 4.3.3 Competitive dashboard analysis
      • 4.3.3.1 Market differentiators
  • 4.4 Private companies
    • 4.4.1 List of key emerging companies' /technology disruptors/innovators
    • 4.4.2 Funding outlook
    • 4.4.3 Regional network map
    • 4.4.4 Company market position analysis
    • 4.4.5 Supplier ranking

Chapter 5 Malaria Diagnostics Market: Technology Estimates and Trend Analysis

  • 5.1 Definition and Scope
  • 5.2 Technology Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Malaria Diagnostics Market, by Technology, 2017 - 2030 (USD Million)
  • 5.5 Market Size & Forecasts and Trend Analysis, 2017 to 2030 by Technology
    • 5.5.1 Microscopy
      • 5.5.1.1 Microscopy market, 2017 - 2030 (USD Million)
    • 5.5.2 Rapid Diagnostic Tests (RDTs)
      • 5.5.2.1 Rapid Diagnostic Tests (RDT)market, 2017 - 2030 (USD Million)
    • 5.5.3 Molecular Diagnostic Tests
      • 5.5.3.1 Molecular Diagnostic Tests market, 2017 - 2030 (USD Million)
      • 5.5.3.1.1 Conventional PCR market, 2017 - 2030 (USD Million)
      • 5.5.3.1.2 Real-Time PCR (qPCR or quantitative PCR) market, 2017 - 2030 (USD Million)

Chapter 6 Malaria Diagnostics Market Regional Estimates & Trend Analysis, by Technology

  • 6.1 Regional Market Snapshot
  • 6.2 Regional Market Share and Leading Players, 2021
    • 6.2.1 Africa
    • 6.2.2 Southeast Asia
    • 6.2.3 Eastern Mediterranean
    • 6.2.4 Western Pacific
    • 6.2.5 Americas
    • 6.2.6 Europe
  • 6.3 Market Share Analysis by Country/State
    • 6.3.1 Africa
    • 6.3.2 Southeast Asia
    • 6.3.3 Eastern Mediterranean
    • 6.3.4 Western Pacific
    • 6.3.5 Americas
    • 6.3.6 Europe
  • 6.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.4.1 Latin America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
    • 6.4.5 Middle East & Africa
    • 6.4.6 Europe
  • 6.5 Market Size, & Forecasts and Trend Analysis, 2017 to 2030
  • 6.6 Africa
    • 6.6.1 Africa Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.6.2 Nigeria
      • 6.6.2.1 Nigeria Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.6.3 Democratic Republic of Congo
      • 6.6.3.1 Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.6.4 Uganda
      • 6.6.4.1 Uganda Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • 6.7 Southeast Asia
    • 6.7.1 South East Asia Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.7.2 India
      • 6.7.2.1 India Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.7.3 Myanmar
      • 6.7.3.1 Myanmar Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.7.4 Indonesia
      • 6.7.4.1 Indonesia Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • 6.8 Eastern Mediterranean
    • 6.8.1 Eastern Mediterranean Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.8.2 Saudi Arabia
      • 6.8.2.1 Saudi Arabia Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.8.3 Pakistan
      • 6.8.3.1 Pakistan Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • 6.9 Western Pacific
    • 6.9.1 Western Pacific Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.9.2 China
      • 6.9.2.1 China Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.9.3 Papua New Guinea
      • 6.9.3.1 Papua New Guinea Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.9.4 Cambodia
      • 6.9.4.1 Cambodia Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • 6.10 Americas
    • 6.10.1 Americas Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.10.2 Venezuela
      • 6.10.2.1 Venezuela Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.10.3 Brazil
      • 6.10.3.1 Brazil Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.10.4 Colombia
      • 6.10.4.1 Colombia Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
  • 6.11 Europe
    • 6.11.1 Europe Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.11.2 Turkey
      • 6.10.2.1 Turkey Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.11.3 France
      • 6.10.3.1 France Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.11.4 U.K.
      • 6.10.4.1 U.K. Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)
    • 6.11.5 Germany
      • 6.10.5.1 Germany Market Size, & Forecasts and Trend Analysis, 2017 to 2030 (USD Million)

Chapter 7 Company Proflies

  • 7.1 Access Bio, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Product Benchmarking
    • 7.1.3 Strategic Initiatives
  • 7.2 Abbott
    • 7.2.1 Company Overview
    • 7.2.3 Financial performance
    • 7.2.2 Product Benchmarking
    • 7.2.3 Strategic Initiatives
  • 7.3 Premier Medical Corporation Ltd
    • 7.3.1 Company Overview
    • 7.3.2 Product Benchmarking
  • 7.4 Sysmex Partec GmbH
    • 7.4.1 Company Overview
    • 7.4.2 Product Benchmarking
    • 7.4.3 Strategic Initiatives
  • 7.5 bioMerieux
    • 7.5.1 Company Overview
    • 7.5.2 Product Benchmarking
    • 7.5.3 Strategic Initiatives
  • 7.6 Beckman Coulter, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Siemens Healthineers
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
  • 7.8 Leica Microsystems GmbH
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 Nikon Corporation
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic initiatives
  • 7.10 Olympus Corporation
    • 7.10.1 Company Overview
    • 7.10.2 Financial Performance
    • 7.10.3 Product Benchmarking
    • 7.10.4 Strategic initiatives
  • 7.11 Bio-Rad Laboratories, Inc.
    • 7.11.1 Company Overview
    • 7.11.2 Financial Performance
    • 7.11.3 Product Benchmarking